Skip to main content
PLOS One logoLink to PLOS One
. 2023 Nov 8;18(11):e0292757. doi: 10.1371/journal.pone.0292757

Characterization of polarization states of canine monocyte derived macrophages

Qingkang Lyu 1,2, Edwin J A Veldhuizen 1, Irene S Ludwig 1, Victor P M G Rutten 1,3, Willem van Eden 1, Alice J A M Sijts 1, Femke Broere 1,4,*
Editor: Kenji Fujiwara5
PMCID: PMC10631683  PMID: 37939066

Abstract

Macrophages can reversibly polarize into multiple functional subsets depending on their micro-environment. Identification and understanding the functionality of these subsets is relevant for the study of immune‑related diseases. However, knowledge about canine macrophage polarization is still in its infancy. In this study, we polarized canine monocytes using GM-CSF/IFN- γ and LPS towards M1 macrophages or M-CSF and IL-4 towards M2 macrophages and compared them to undifferentiated monocytes (M0). Polarized M1 and M2 macrophages were thoroughly characterized for morphology, surface marker features, gene profiles and functional properties. Our results showed that canine M1-polarized macrophages obtained a characteristic large, roundish, or amoeboid shape, while M2-polarized macrophages were smaller and adopted an elongated spindle-like morphology. Phenotypically, all macrophage subsets expressed the pan-macrophage markers CD14 and CD11b. M1-polarized macrophages expressed increased levels of CD40, CD80 CD86 and MHC II, while a significant increase in the expression levels of CD206, CD209, and CD163 was observed in M2-polarized macrophages. RNAseq of the three macrophage subsets showed distinct gene expression profiles, which are closely associated with immune responsiveness, cell differentiation and phagocytosis. However, the complexity of the gene expression patterns makes it difficult to assign clear new polarization markers. Functionally, undifferentiated -monocytes, and M1- and M2- like subsets of canine macrophages can all phagocytose latex beads. M2-polarized macrophages exhibited the strongest phagocytic capacity compared to undifferentiated monocytes- and M1-polarized cells. Taken together, this study showed that canine M1 and M2-like macrophages have distinct features largely in parallel to those of well-studied species, such as human, mouse and pig. These findings enable future use of monocyte derived polarized macrophages particularly in studies of immune related diseases in dogs.

1. Introduction

Dogs are considered an attractive pre-clinical animal model for human disease studies due to the natural occurrence of many, inherited, immunological diseases, including lymphomas, osteosarcoma, autoimmune hemolytic anemia and atopic dermatitis [13]. Considering the general importance of macrophages in multiple immune diseases, the ability to identify canine macrophages and their functional subsets is a valuable asset for studies in the canine species. To date, characterization of macrophages from different sources such as bone marrow, peripheral blood mononuclear cells, peritoneum and spleen have mostly been studied in mice [4]. However, with the exception of PBMCs, it is difficult to obtain these materials from other mammals like dogs, therefore well-characterized monocyte-derived macrophages could serve as a valuable source of macrophages for relevant in vitro studies.

The macrophage as a main member of the monocyte/macrophage phagocytotic system (MPS), plays a crucial role in probably all immune responses, including the regulation of inflammation, homeostasis, and tissue repair [5]. As a group of important antigen presenting and cytokine producing cells, macrophages serve as connectors and regulators between innate and adaptive immune responses, balancing anti- and pro-inflammatory responses [6]. Depending on signals in the local microenvironment, macrophages may polarize into functional subsets [7]. Initially, two main macrophage subsets were identified in mice, namely, classically activated (M1) and alternatively activated (M2) macrophages [8, 9]. In this classical view, M1 macrophages have a fried-egg appearance and produce pro-inflammatory cytokines, such as IL-6, IL-12, IL-23, IL-1β and TNF-α [10]. These cells also express high levels of surface markers such as CD40, CD80, CD86 and MHC II, which increases their antigen-presenting ability, and are associated with a role in a more-general Th1 response. In contrast, M2 macrophages have an elongated spindle-like appearance and produce anti-inflammatory cytokines, such as IL-4, IL-13, IL-10 or TGF-β [11]. They have increased surface expression of CD206, CD209 and CD163 on the cell surface [12], and are functionally characterized by a potent phagocytic capacity, tissue repair and wound healing activity, and associated with a more-general Th2 response [13].

Nowadays it has become clear that these subsets are only artificially defined, extreme, states of the continuous spectrum of all differentiation states that macrophages can have due to their plasticity and that this polarization is actually reversible [14]. Several other differentiation states such as Mox M(hb) and M4 have been defined besides the M1/M2 subsets, while the M2 subset is now divided in several sub-subsets (M2a-c), defined either by their activating ligands and receptors or their production of cytokines [1517]. Although this labeling of subsets is supposed to provide some clarity, it is obvious that due to plasticity of macrophages, small changes in their microenvironment can have relatively large effects on gene- and protein expression, and thereby functionality, which cannot be captured completely in descriptive labels. However, considering the difficulty of experimentation with macrophages in vivo, well defined in vitro culture systems providing well defined polarized macrophages are an important asset to predict macrophage function in vivo.

Tools available for characterization and use of polarized macrophages in dogs are limited. In 2017 and very recently in 2022, the polarization into M1 and M2 macrophages derived from monocytes was described [18, 19] including microRNA analyses of genes and pathways related to polarization. Canine histiocytic cells (DH82 cells) and monocytes polarized towards two subsets resembling M1 and M2a macrophages, were described in a similar way, but based on a relatively small set of genes and markers [20].

In the present study we describe in vitro polarization of canine monocytes into M1 and M2 macrophage, using GM-CSF / IFN-γ + LPS for M1 polarization, or M-CSF/ IL-4 for M2 polarization. The goals of our study were to confirm reproducibility of this methodology to obtain M1 and M2 macrophages in dogs, including appearance of descriptive M1/M2 characteristics. Furthermore, to relate cellular functionality of macrophage M1/M2 subsets as exemplified by phagocytosis to their phenotypes.

2. Materials and methods

2.1 Canine PBMCs and monocytes isolation

Dog blood samples and buffy coats were obtained from the Companion animal clinics, Faculty of Veterinary Medicine, Utrecht University, under owner’s consent. Collection of samples was conducted by professional veterinarians at the department of Clinical Sciences of Companion Animals of Utrecht University. Donors were healthy male and female dog of different breeds between 2 and 8 years old. Blood of >10 dogs was donated, not more often than once every half year. Peripheral blood mononuclear cells (PBMCs) were isolated from canine buffy coats by gradient centrifugation using Histopaque-1077 (Sigma Aldrich, Gillingham, United Kingdom). Briefly, buffy coats were diluted 1:1 in phosphate buffered saline (PBS) and gently layered on top of an equal volume of Histopaque-1077. The gradient was centrifuged for 30 min at 800 ×g at room temperature without braking. The layer of PBMCs located on top of the Histopaque-1077 was collected and washed three times with PBS containing 0.5% fetal calf serum (FCS) and 2 mM EDTA (MACS buffer). Subsequently, monocytes were isolated from the PBMCs by means of MACS using mouse anti-CD14 antibody to label the cells and anti-mouse IgG magnetic Microbeads (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) using standard protocols.

2.2 Culture and polarization of canine monocytes

Isolated CD14+ monocytes were directly seeded into a 24-well plate in 1 ml at a density of 7.5×105 cells/well. Cells were cultured in RPMI-1640 GlutaMAX (Life TechnologiesTM Ltd., Paisley, Scotland, UK) supplemented with 5% fetal bovine serum (BODINCO B.V., The Netherlands), and 1% penicillin/streptomycin (Life TechnologiesTM Ltd., Paisley, Scotland, UK) at 37°C and 5% CO2. To generate monocyte-derived macrophages (MDMs), canine CD14+ monocytes were incubated with canine recombinant GM-CSF (R&D systems, Abingdon, United Kingdom) or recombinant human macrophage colony stimulating factor (M-CSF) (GibcoTM, Thermo Fisher Scientific, Carlsbad, USA). The medium was refreshed every 2 days. At day 5, GM-CSF treated monocytes were activated with 20 ng/ml recombinant canine IFN-γ (R&D system, Abingdon, United Kingdom) and 100 ng/ml LPS from Escherichia coli O111:B4 (Sigma-Aldrich, Saint Louis, MO, USA) for M1 polarization; M-CSF treated monocytes were activated with 40 ng/ml recombinant canine IL-4 (R&D system, Abingdon, United Kingdom) for M2 polarization.

Control, M0 cells, representing undifferentiated monocytes were derived by culturing monocytes in exactly similar conditions, except that no stimuli (M/GM-CSF, IFN- γ and LPS) were added. M1, M2 polarized macrophages and M0 monocytes were harvested on day 7 for phenotypical characterization, mRNA isolation and phagocytosis assays.

2.3 Morphological characterization of canine monocyte-derived macrophages by phase-contrast microscopy

For monocyte-derived macrophages, the morphology of polarized cells and control undifferentiated monocytes was determined in the wells after 3, 5, and 7 days of culture using an inverted phase-contrast microscope (‘Eclipse TS100’ Nikon Instruments Europe B.V., Amstelveen, The Netherlands) and ImageFocus v3.0.0.2. Data were processed using Fiji imageJ. software Afterwards M0, M1 and M2 cells were harvested for further analyses.

2.4 Phenotypic characterization of monocyte-derived macrophages by flow cytometry

For flow cytometric analysis, at day 7, undifferentiated monocytes, and MDM-derived M1 and M2 cells were washed with cold PBS and detached by gentle scraping to obtain monocyte-derived macrophages. Cells were transferred into a round-bottom 96-well plate at a density of 2×105 cells/well. Fc receptors were blocked with 10% autologous dog serum for 30 min to avoid non-specific antibody binding. To determine their phenotype, macrophages were stained for 30 min on ice using antibodies specific for CD14, CD40, CD80, MHC II, CD206, CD83, CD86, CD32, CD11b, or isotype controls (see Table 1). Cells were washed 3 times with FACS buffer (2% FCS in FBS), incubated with secondary or streptavidin conjugated antibodies for another 30 min on ice, washed again, and at least 10,000 events were analyzed using a CytoFLEX LX flow cytometer (Beckman Coulter Inc., CA, USA). To exclude dead cells from analyses, the ViaKrome 808 Fixable Viability Dye (Beckman Coulter, Woerden, Netherlands) was used. Data acquired were analyzed with FlowJo Software v.10.5 (FlowJo LCC, Ashland, USA).

Table 1. List of antibodies used for flow cytometry.

Antigen Target species Clone Isotype Dilution Source
CD14, vioblue Mouse anti-human/canine TÜK4 Mouse IgG2a κ 1:100 Miltenyi Biotec
CD11b, biotin Mouse anti-dog CA16.3E10 Mouse IgG1 1:100 P. Moore
CD32B+CD32A biotin Mouse anti-human/canine AT10 Mouse IgG1 1:50 Abcam
CD40, R-PE Mouse anti-human/canine LOB7/6 Mouse IgG2a 1:25 BIO-RAD
CD80, FITC Hamster anti-mouse/canine 16-10A1 Hamster IgG2 1:100 BD Biosciences
CD86, unconjugated Mouse anti-dog CA24.3E4 Mouse IgG1 1:50 P. Moore
CD83, APC Mouse anti-human/canine HB15e Mouse IgG1, κ 1:50 Biolgend
CD206, APC/Cyanine7 Mouse anti-human/canine 15–2 Mouse IgG1, κ 1:50 Biolegend
MHC II, APC Rat anti-canine YKIX334.2 Rat IgG2a, κ 1:50 eBioscience™
GaM-IgG1-PerCP Mouse IgG - IgG 1:100 Santa Cruz Biotechnology
streptavidin -PE - - - 1:2000 BD Biosciences

2.5 RNA isolation from canine MDMs, library preparation and RNA sequencing

After 7 days of polarization as described above, a Qiagen RNeasy mini kit was used to extract total RNA from M0 monocytes, and M1 and M2 macrophages. In addition, newly isolated CD14+ cells and the CD14 depleted (CD14D) fraction of the PBMCs were included as controls. RNA concentration was measured using a NanoDrop-1000 Spectrophotometer (Isogen Lifescience B.V., Utrecht, The Netherlands). RNA quality, library preparation and RNA sequencing were done by Novogene Co., Ltd. More specifically, RNA samples were analyzed on 1% agarose gels and a spectrophotometer (NanoPhotometer,IMPLEN, CA, USA) was used to monitor RNA degradation, contamination, and purity. The RNA Nano 6000 Assay Kit from the bioanalyzer 2100 system (Afilent Technologies, CA, USA) was used to assess RNA integrity and quantity. RNA samples with RNA Integrity Number (RIN) ≥ 8 were included in the following analysis.

Following quality control of RNA, up to 1 μg per sample was used for library preparation using NEBNext® UltraTM RNA Library Prep Kit for Illumina® (NEB, USA) according to the manufacturer’s instructions. Briefly, PolyA-containing mRNA was enriched from total RNA using poly-T oligo-attached magnetic beads. RNA fragmentation was performed using divalent cations under elevated temperature in NEBNext First Strand Synthesis Reaction Buffer (5X). First-strand cDNA was synthesized using M-MuLV Reverse Transcriptase (RNase H-) with random hexamer primer. Second-strand cDNA was synthesized using DNA Polymerase I and RNase H. Next, 3’ end adenylation and adaptor ligation were carried out. cDNA fragments of 150–200 bp were purified with the AMPure XP system (Beckman Coulter, Beverly, USA) for library fragments. Library quality was evaluated using the Agilent Bioanalyzer 2100 system. Subsequently, cluster generation was carried out on a cBot Cluster Generation System using PE Cluster Kit cBot-HS (Illumina). Finally, the sequencing was performed on a NovaSeq 6000 System (Illumina, San Diego, CA) with paired-end read configuration.

2.6 Reads processing and differential expression analysis from RNA-seq data

In order to get clean reads, reads meeting the following conditions were filtered out from the sequenced/raw reads: 1) containing adapters, 2) the quality value of over 50% bases of the read is less than or equal to 5, 3) percentage of non-determined bases is over 10%. Clean reads were mapped to the Canis familiaris.canfam 3.1 reference genome using HISAT2 software v2.0.5 [21, 22].

Differential gene expression between groups was calculated using DESeq2 package from Bioconductor) open source software for bioinformatics) with default parameters in the program R. Genes with read counts < 2 in all samples were filtered out from DEG testing. Genes with |log2 (fold change)| ≥ 1 and an adjusted p value < 0.05 were considered as differentially expressed genes (DEGs). DEGs were assessed through 6 group comparisons: M0 vs M1, M0 vs M2, M1 vs M2, CD14+ vs M0, CD14+ vs M1, and CD14+ vs M2. Heat map generation and cluster analysis were performed using the R package “pheatmap”. Volcano plots were generated with “ggplot2” in R packages displayed DEGs for each comparison. Principal component analysis (PCA) was conducted based on normalized Fragments Per Kilobase Million (FPKM) to show the similarity and difference of M0, M1, M2, CD14+ and CD14D populations.

2.7 Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway enrichment analysis

The annotation of sorted DEGs were performed using the GO and KEGG database. DEGs from each group comparison were used for GO and KEGG enrichment analysis using the R package ClusterProfiler v3.8.1. GO terms enriched within Biological Process (BP), Cellular Component (CC), and Molecular Function (MF) were assessed. In addition, the enrichment of DEGs within KEGG pathways were explored. The differences between groups compared were evaluated using Gene Set Enrichment Analysis (GSEA). GO terms and KEGG pathways with a corrected p value < 0.05 were determined as statistically significant enrichment. The top 20 most enriched GO terms and KEGG pathways in DEGs were shown.

2.8 Phagocytosis assay by flow cytometry

Phagocytic capacity of canine MDMs was evaluated using 1 μm crimson carboxylate-modified FluoSpheres fluorescent beads (Life Technologies Corporation, Eugene, USA). Specifically, canine MDMs were co-cultured with FluoSpheres fluorescent beads at a ratio of 10:1 (bead: cell) for 4 h on day 7. Then cells were washed three times to remove non-phagocytized beads. Harvested cells were washed 2 times with PBS containing 5 mM EDTA and transferred into a 96-well U-bottom plate. Next, the cells were stained with ViaKrome 808 Fixable Viability Dye (Beckman Coulter, Woerden, The Netherlands) for 30 min on ice to exclude dead cells from analyses. Afterwards, the cells were washed twice and fixed in 4% paraformaldehyde (Alfa Aesar, Kandel, Germany) for 15 min at room temperature. Finally, the cells (at least 10,000 events) were analyzed in a CytoFLEX LX flow cytometer (Beckman Coulter Inc., CA, USA) using the 638 nm laser and the 660/10 fluorescent channel. Data were analyzed using FlowJo Software v.10.5 (FlowJo LCC, Ashland, USA) and GraphPad Prism 8.3.0 (Graphpad Software LLC., San Diego, USA). The first fluorescent peak showing in the histogram was considered as cells with a single bead. The average bead uptake and the change in bead uptake compared to (M0) undifferentiated monocytes was calculated using formulas described in literature [23].

Bead/cell=MFItotalMFI1bead/cellandfoldchange=beads/cellM1orM2beads/cellM0

2.9 Assessment of bead internalization by confocal microscopy

To confirm the internalization of beads in polarized macrophages, CD14+ monocytes were grown on sterilized 12 mm coverslips in a 24-well plate. After 7 days of polarization and activation, 1 μm crimson carboxylate-modified FluoSpheres fluorescent beads (Life Technologies Corporation, Eugene, USA) were added into the 24-well plate at a ratio of 10:1 (beads: cells), and incubated for 4 h at 37°C. Then macrophages were washed three times with cold Hank’s balanced salt solution (HBSS) (Gibco, Paisley, UK) to remove non-phagocytized beads, followed by staining of the macrophage membranes with 2 μg/ml Alexa Fluor 488 conjugated Wheat germ agglutinin (WGA) (Life Technologies Corporation, Eugene, USA) in HBSS for 10 min at 37°C. Subsequently, macrophages were washed twice with HBSS to remove excess WGA and fixed with 4% paraformaldehyde for 15 min at room temperature. After washing twice, coverslips with macrophages were mounted on polysine slides (Thermo Scientific, Braunschweig, Germany) with FluorSave Reagent (Millipore, San Diego, USA). Finally, uptake and internalization of beads were confirmed using the TCS SPE-II spectral confocal microscope and LAS-AF software (Leica Microsystems B.V., Amsterdam, The Netherlands). Z-stacks were made to determine whether beads were completely internalized. The images from confocal microscopy were analyzed using Fiji imageJ.

2.10 Statistical analysis

Statistical analysis was conducted using GraphPad Prism 8.3.0 (Graphpad Software LLC., San Diego, USA). Two-way ANOVA tests with multiple comparisons were used to determine statistical differences. The mixed effects model was used in case of missing values. The mRNA sequencing data were analyzed using R program and appropriate R packages as indicated above. Data were harvested from at least three donor dogs. All independent experiments were repeated at least three times. Each P value is adjusted to account for multiple comparisons. *p<0.05 and **p<0.01 were considered as significant difference and highly significant, respectively.

3. Results

3.1 Morphologic characterization of canine monocyte-derived macrophages

In order to obtain canine macrophages in vitro, CD14+ cells, derived from canine PBMCs were polarized into classically activated M1 (GM-CSF/ IFN-γ + LPS) and alternatively activated M2 macrophages (M-CSF/ IL-4). Phase contrast microscopic analysis of the cultured canine MDMs, showed morphological changes between M0 monocytes and MDM subtypes M1 and M2 from day 5 onwards (Fig 1A). At day 3, all subsets had a small and roundish shape, but at day 5, M1-polarized macrophages started to display morphological changes such as increased size, and a flat, roundish, and amoeboid shape. Some M1 cells adopted a typical well-spread “fried-egg” phenotype (red arrow). A small portion of cells displayed stretched, spindle-like morphology at day 5 in M2-polarized macrophages (blue arrow). At day 7, these morphological changes were more pronounced, M1-polarized macrophages were differentiated into homogenous round cells with a dominant amoeboid and “fried-egg” phenotype, while a large portion of M2-polarized macrophages had obtained an elongated spindle morphology (Fig 1A). Flow cytometry analysis showed that M1-polarized macrophages were significantly bigger and more granular than M0-monocytes and M2- macrophages (Fig 1B and 1C). Non-viable cells were excluded from analysis (as shown in S1 Fig). Thus, M1 and M2-skewed canine macrophages exhibit clearly distinct morphology.

Fig 1. Morphological changes between canine undifferentiated monocytes and M1 and M2 polarized macrophages.

Fig 1

(A) Representative images showing morphology of undifferentiated monocytes (M0) and monocyte derived M1 and M2 macrophages at day 3, 5 and 7 of culture. M1 macrophages exhibit a large and round shape with amoeboid and flat morphology (red arrow), while M2 macrophages exhibit a stretched and spindle-like morphology (blue arrow). Scale bar = 100 μm. (B) Flow cytometry forward scatter (FSC) profiles indicative of size of monocyte-derived macrophages (C). Geometric mean (gMFI) FSC based size difference between M0, M1 and M2 cells is summarized. Data are presented as mean ± SD, data obtained from 3 different donors measured in triplicates. gMFI: geometric mean of fluorescence intensity, SSC: side scatter, FSC: forward scatter.

3.2 Phenotypic characterization of canine monocyte-derived macrophages

In order to phenotypically characterize in vitro polarized canine MDMs, flow cytometry was performed on day 7 of culture. A set of surface markers related to macrophage activation was selected based on previous studies [24, 25]. As expected, pan-macrophage markers CD14 and CD11b were highly expressed by M0 undifferentiated monocytes, M1 and M2 cells (Fig 2A) with significantly increased CD11b expression on M1 and M2 MDMs compared to M0 undifferentiated monocytes. Interestingly, M1 MDMs expressed significantly higher levels of activation markers CD40, CD80, CD86 and MHC II (Fig 2A), which are often used as M1 markers in human and mouse studies, compared to undifferentiated M0. MHC II expression had also increased in M2 macrophages. In contrast, in M2 macrophages, surface receptors CD32, CD163 and CD206, CD209 were significantly higher than either M0 or M1 cells, while CD83 was actually reduced in M1 (but not raised in M2 vs M0). These results indicate that, similar to other species, there are distinct differences in expression of specific surface markers between M1 and M2-skewed canine macrophages.

Fig 2. Flow cytometric analysis of surface markers expressed by canine monocyte derived macrophages.

Fig 2

Undifferentiated monocytes and polarized canine MDMs (M0, M1 and M2) were collected on day 7, stained with a set of macrophage surface markers (see Table 1) and analyzed by flow cytometry. (A) Representative histogram obtained from one donor. Each overlaid histogram represents an overlay of the respective monoclonal antibody and fluorescence-minus-one (FMO) controls (shaded black lines) for the indicated marker. Green line: M0, red line: M1, blue line: M2. (B) The bar graphs represent the means of geometric fluorescence intensity (MFI) ± SD of positive cells in 3 different donors measured in triplicates. p values of M1 and M2 are relative to M0.

3.3 Monocyte-derived M1 and M2 macrophages depict different gene profiles

To investigate the gene expression profiles of undifferentiated monocytes and monocyte-derived M1 and M2 macrophages, mRNA was sequenced. After filtering out genes with read counts < 2, 17,929 genes were identified expressed in the 5 cell types: M0 monocytes, M1 and M2 polarized MDMs and freshly isolated CD14+ and CD14-depleted cells (CD14D) (S1 Table). Fig 3A shows the distribution of genes among the different subsets in a Venn diagram: M1- and M2- polarized macrophages expressed 10,030 genes in common and 440 versus 816 specific in M1 and M2 macrophages, respectively. In the three-groups-comparison M0 vs M1 vs M2 group, 9,895 genes were expressed by M0, M1 and M2 macrophages. In addition, 244 unique genes in M0 monocytes, 272 unique genes in M1 macrophages and 246 unique genes in M2 macrophages (Fig 3A) were expressed. The Venn diagram for a five group comparison including CD14+ and CD14-depleted (CD14D) showed that despite larger partial overlaps each group still has a certain set of group specific genes. To identify differentially expressed genes (DEGs) in the different groups, p <0.05 and |log2(FC)|>1 were set as criteria. Based on these, 13,052 differentially expressed genes (DEGs) were identified (S2 Table). Results were plotted as a heat map showing the expression levels of DEGs of each sample (n = 3), from which the expression trend can be clearly seen (Fig 3B).

Fig 3. Gene expression profiles of undifferentiated monocytes (M0), M1, M2, CD14+ and CD14-depleted cells, shown by Venn diagram and heat map.

Fig 3

Venn diagrams showing the distribution of expressed genes in the 5 groups, comparisons are shown for M1 vs M2; M0 vs M1 vs M2; and M0 vs M1 vs M2 vs CD14+ vs CD14D. The number of overlapping and uniquely expressed genes are shown. The overlapping regions indicated the number of co-expressed genes in two or more samples. M0, M1 and M2: different polarization states of macrophages. CD14:freshly isolated CD14+ cells from PBMC. CD14D: CD14+ depleted cell population of PBMC. (B) Heat map with cluster analysis showing differentially expressed genes within all comparison groups. Adjusted p value < 0.05 was used as a cutoff. Each column indicates one sample. Each row indicates a single gene. The color ranges from red to blue represents the expression level of genes from high to low. The log2(FPKM+1) value was used as cut off for cluster analysis. Data were obtained from 3 different donors. FPKM: Fragments Per Kilobase Million.

Comparisons between 2 groups reveal interesting details on how polarization of monocytes has changed gene expression of the different MDM subsets. Compared to M0 monocytes, most DEGS (3199), 1649 up- and 1550 down regulated, were observed in the M1 group (Fig 4A), a much lower number of DEGs, 1882 were observed in the M2 macrophages (901 up, 981 down, Fig 4B). A total of 3124 DEGs were found in the M1 vs M2 comparison, with 1688 upregulated and 1436 downregulated genes (Fig 4C). In pairwise comparisons including the control CD14+ cells, there were 6,092, 6,283 and 6,330 DEGs between CD14+ and MO, M1 and M2 respectively, with approximately evenly distributed numbers of up- and downregulated genes in each comparison (S1 Fig). The top 50 up- and down-regulated genes for each pairwise comparison of these 4 groups (M0, M1, M2 and CD14+) are listed in S3 Table.

Fig 4. Polarized macrophage subsets show distinct gene expression profiles.

Fig 4

Volcano plots depicting differentially expressed genes in different comparison groups. (A) comparison between undifferentiated monocytes (M0) and M1, (B) M0 and M2, and (C) M1 vs M2. Each volcano plot was shown as log2 (fold change) (x-axis) vs -log10(p-adj) (y-axis). M0 monocytes are considered as control in (A) and (B). M2 macrophages are considered as control in (C). Genes with adjusted p value < 0.05 and |log2(FC)| > 1 are regarded as statistically significantly different. The horizontal line at y ≈ 1.303 indicates p = 0.05. Vertical lines at x = 1 or -1 indicate log2(FC) = 1 or -1. Red dots, blue dots and gray dots represent up-regulated, down-regulated, and non-significant DEGs, respectively. The name of top 10 DEGs with p < 0.001 and |log2(FC)| ≥ 8 were labeled out. FC: fold change; DEGs: differentially expressed genes. (D) Principal-component analysis of all genes expressed based on FKPM in M0, M1, M2, CD14+ and CD14D.Data obtained from 3 different donors.

An interesting observation can be made from the large pool of DEGs when specifically the expression of several pro- and anti-inflammatory cytokines is studied (S2 Fig). Clearly, M1 macrophages showed higher expression of M1 marker genes, IL-6, IL-1β, TNF-α, iNOS, LXN, IL-12A and IL-12B, while CCL2 and COX2 expression were decreased. In addition M2 marker genes MS4A2, TGF-β, IL-10 were shown to be expressed at a higher level in M2 than in M1 macrophages.

To further evaluate clustering of gene profiles, principal component analysis (PCA) was performed. This showed that M2 macrophages clustered with M0 monocytes, while M1, CD14+ and CD14D were clearly distinct from each other (Fig 4D). Overall, the transcriptomic data confirmed that the differentiation protocols used indeed resulted in monocyte-derived M1 and M2 macrophages with significantly different gene profiles and activation patterns.

3.4 DEGs of M1 and M2 MDMs were enriched in different GO terms and KEGG pathways

To determine the main changes in biological processes during polarization of MDMs, gene ontology (GO) and KEGG enrichment analysis of all DEGs was performed using the “clusterProfiler” package in R. The top 20 of most enriched GO terms and KEGG pathways are shown in Fig 5. As expected, the data convincingly show that many of the processes relate to immune function of macrophages. The top 2 GOs for M1 polarization (both vs M0 as M2), within the Biological Process (BP) group are “immune system process” and “immune response”, while the KEGG analyses results include functional pathways related to Th17 cell differentiation, TNF signaling and Toll-like receptor signaling. Comparable results were seen in the M1 vs M2 comparison, which also shows the “immune system process” and “immune response” groups in the GO analysis with the highest number of DEGs, while the KEGG analysis includes Th1, Th2 and Th17 cell differentiation and also TNF signaling in the top scoring pathways. Differences between M0 and M2 included other GO terms, enriched DEGs were mainly associated with “GTPase activator activity” and “G-protein coupled receptor binding” in the Molecular Functions (MF) group. The KEGG Pathway analyses did not provide a clear picture how M0 and M2 differ immunologically, since many of the most pathways cannot directly be linked to immune function, with the exception of the chemokine signaling pathway.

Fig 5. The GO terms and KEGG pathway enrichment analysis of DEGs between undifferentiated monocytes and M1 and M2 MDMs.

Fig 5

DEGs including both up- and down-regulated genes from each compared group were subjected to GO and KEGG analysis. The top 20 most enriched GO terms (including BP, CC, and MF) and KEGG pathways of DEGs are shown in comparison between groups, (A, D) M0 vs M1, (B, E) M0 vs M2, and (C, F) M1 vs M2. Blue and green in (A, B, and C) represent BP and MF, respectively. Data obtained from 3 different donors.

Overall, the RNAseq data indicate clearly that also on an gene expression level a substantial difference exists between the macrophage populations. The fact that M1 and M2 differ in many immunological functions, while both M1 and M2 are different from control M0 cells, suggests that M1 and M2 MDMs are distinct populations.

3.5 Phagocytic capacity of canine monocyte-derived macrophages

A functional analysis of the MDMs was performed by examining phagocytic capacity of MDMs using crimson carboxylate-modified FluoSpheres fluorescent beads. These experiments showed that all MDMs were able to take up fluorescent beads (Fig 6), while control M0 monocytes co-cultured with beads at 4°C failed to engulf any beads (data not shown). M0 cells and M2-polarized MDM displayed a significantly higher bead-uptake than M1 cells (p < 0.05) (Fig 6A and 6B). On average, M2-polarized MDMs phagocytized 3 times more beads than M1-polarized MDM (Fig 6C). This observation was further qualitatively confirmed by confocal microscopy (Fig 6D), where less fluorescent beads were observed in M1 MDM. The highest concentration of beads was found in the spindle-like shaped cells in the M2 MDM population. Next, the location of fluorescent beads was visualized by re-constructing a 3-D model of MDMs with Z-stacks, which confirmed bead internalization by MDMs (S1A-S1C Video). These experiments show that in vitro differentiation of macrophages also leads to functional differences between these cells.

Fig 6. Phagocytic capability of canine monocyte derived macrophages.

Fig 6

CD14+ monocytes were polarized and activated for 7 days and incubated with crimson carboxylate-modified FluoSpheres fluorescent beads for 4 h. Undifferentiated monocytes (M0) and M1 and M2-polarized MDMs were harvested. (A) MDMs were gated based on their scatter profile (FSC/SSC) and viability (viakrome). The bead content was analyzed quantitatively by flow cytometry for MDMs. MDMs containing beads were gated as indicated by the black box. Cells with 1 bead per cell are indicated by the red box. A representative flow cytometry plot is shown. (B) MDMs containing beads were depicted as the percentage of phagocytic cells and median fluorescence intensity (MFI). (C) The fold change in bead uptake of M1- and M2-polarized MDMs was calculated as described in materials and methods and compared to undifferentiated M0 monocytes. (D) Confocal microscopy was performed to confirm non-specific phagocytosis by MDMs. Cell membrane was stained by WGA-Alexa Fluor 488 shown in green and FluoSpheres fluorescent beads are shown in red. A 3D model of internalization by MDMs was reconstructed from z-stacks. The corresponding video showing 3D structure can be found in S1A-S1C Video. Data obtained from three independent donors measured in triplicates and shown as mean ± SD. Scale bar = 10 μm.

4. Discussion

Dogs have become an increasingly important translational animal model for chronic, inflammatory and immunological disorders [1, 26]. Macrophages play a crucial role in most immune-associated diseases. In countless studies, macrophages derived from monocytes or monocyte-like cell lines are utilized to understand the biology and differentiation of macrophages. So far, most studies have focused on macrophages from humans and mice, and knowledge on canine macrophages is still scarce. Therefore, availability of well-characterized canine macrophages and macrophage subsets is urgently needed for a better understanding of their biological functions. Here, we present a systematic study of canine macrophages derived from monocytes polarized into 2 different states that resemble M1 and M2 macrophages. Morphology, surface markers, differentially expressed genes and partially functional activity of these macrophage subsets are extensively described, thus providing highly characterized tools for future immunological in vitro studies.

The M1 cells derived from monocytes dominantly displayed a round and amoeboid shape, as visualized by light microscopy. Among M2 cells, populations with small round morphology and with elongated spindle shaped morphology exist. These findings parallel the observations in other species such as humans, mouse and pig [2729]. Also with respect to surface markers, both M1 and M2 cells have many characteristics similar to their human/mouse counterparts. Pan-macrophage markers CD14 and CD11b [30] were highly expressed indicating that these cells indeed maintain macrophage properties during polarization [31]. Co-stimulatory molecules CD40, CD80 and CD86 together with MHC II are essential for antigen presentation and T cell interaction by macrophages and are considered as M1 macrophage markers in many species [3134]. MHC class II showed increased expression in both M1 and M2 polarized cells. CD163 (scavenger receptor), CD206 (mannose receptor), CD209 (DC-SIGN) were indicated to be specific for M2 macrophages in both mouse and human studies [3537]. These features were indeed reflected in M2 polarized canine MDMs. In addition, we found that canine M2 macrophages expressed higher levels of CD32, CD64 and CD83 than M1. So far, the discussion on differences in CD32 and CD64 expression levels between M1 and M2 macrophages varies. A variety of studies described CD32 and CD64 as a M1 macrophage marker [38, 39]. Other studies showed that these are highly induced in M2 macrophages [40, 41], or reported that the expression of CD32 by human macrophages did not change after polarization [24].

Next, we compared the overall gene expression profiles of undifferentiated M0 monocytes and polarized M1 and M2 macrophages by RNAseq, using the CD14+ and CD14+ depleted populations as control. M1 cell signature genes include IL-6, IL-1β, TNF-α, iNOS, IL-12 having pro-inflammatory role, while TGF- β, arginase1 and IL-10 are regarded as M2 signature genes playing anti-inflammatory role [10, 13]. These genes were found in canine M1 and M2 cells as well, respectively. The GO and KEGG analyses revealed that many immune related pathways were affected by the polarizing culture conditions. For example when specifically upregulated genes were considered in M1 compared to M0 control cells, significantly enriched GO terms included immune system processes, cytokine and chemokine activity, antigen processing and presentation, G−protein coupled receptor binding, proteasome complexes, while signaling pathways included Epstein−Barr virus infection, tuberculosis, TNF signaling pathway, Th1 and Th2 cell differentiation, the TNF signaling pathway, Th17 cell differentiation, and the chemokine signaling pathway. M1 vs M2 comparison revealed partially similar processes and pathways highlighting that indeed many immune functions were affected by polarization. Although functional specifics cannot yet be deduced, the overwhelming data set does provide a detailed database for prediction and explanation of macrophage subset behavior in experimental immunological settings.

The change of phenotypes and gene profiles is often accompanied by a change of functional activity [42], and ultimately the functionality of immune cells is arguably the most important readout for immunological characterization. Phagocytosis is one of the main functions of macrophages, which is modulated by a variety of phagocytic receptors. Using latex beads, a change in phagocytosis capacity was observed with M2-polarized MDMs exhibiting the strongest phagocytic capacity and M1 having reduced phagocytic capacity compared to M0 monocytes. In agreement with these results, other studies have also shown that human M2 macrophages displayed a higher phagocytosis capacity than M1 macrophages [24, 43, 44]. However, in contrast with our results, other studies have demonstrated that human M1 macrophages actually showed a higher level of phagocytic activity [4547].

The methodology for polarization of macrophages using GM-CSF/IFN-γ/LPS and M-CSF/IL-4 is widely used in literature. The contribution of each of these factors to polarization is not well described for canine macrophages, but the growth factors GM-CSF and M-CSF likely have a prominent role in this. Macrophages are actually unique in responding to 2 different growth factors [48], where M-CSF (also known as CSF-1) binds its receptor CD155 activating several pathways including ERK, PI3K, PKC and MAPK. GM-CSF (CSF-2) signals through a different receptor, CD116 activating STAT5, ERK, NF-B, and IRF5 [17]. Indeed in human studies monocyte to macrophage maturation in the presence of M-SCF or GM-CSF only already led to large phenotypic differences [49, 50] and they are in itself already considered M1 and M2 stimuli [17]. However, in transcriptome analyses, addition of IL-4 to M-CSF stimulated macrophages led to an additional upregulation of 104 transcripts overly representing M2-associated cytokines [51]. For GM-CSF alone stimulate macrophages many M1 genes were upregulated, including typical M1 cytokines, but addition of LPS (signaling through TLR4) heavily increased the production of several typical M1 cytokines such as IL6 and IL-1β [17]. Although there is no consensus for the perfect polarization method, our experimental setup was specifically chosen to enable a good comparison of characteristics between canine polarized macrophages and macrophages of other species described in literature. In addition an important goal of these studies was also to determine the robustness and reproducibility of producing canine monocyte derived M1 and M2 macrophages. Therefore our methodology to obtain monocyte derived macrophages was largely similar in setup to earlier studies [18, 19] with the exception that our study included CD14+ cells and, compared to Chow et al., used different growth factors for polarization. Nevertheless, overall, obtained M1 and M2 subsets were comparable between all studies with respect to morphology, and upregulation of several M1 and M2 surface markers. For example, expression of CD206 was consistently higher in M2 than M1 macrophages in all studies. However, there were also several differences, such as in MHCII and CD40 expression levels on M1, and in CD32 and CD163 levels on M2 macrophages. At gene expression level, the fold-differences in gene expression (using microRNA) were particularly high in the study of Heinrich et al. [18], but numbers of genes affected were comparable. Remarkably, a comparison of Gene Ontology and KEGG-pathways between studies shows that not one or two specific pathways stand out that define M1 or M2 macrophages. Also completely opposite outcomes were observed regarding the phagocytic capacity of M1 compared to M2 macrophages between the current study and Chow et al. [19] These differences probably reflect the plasticity of macrophages and perhaps small differences in experimental setup. In addition, genetic differences between donors and their health status may contribute to the observed differences. This observed variability indicates that one should be very careful in employing specific surface or gene expression markers as polarization markers, based on a limited number of studies, and that reproducibility of macrophage polarization is actually quite complex. An additional feature, not often tested, is whether the polarized macrophages have retained their plasticity. In other words, M1 macrophages should be still be able to revert to M2 or any other macrophage subtype if the external milieu is changed [52]. This adds another layer of complexity to in vitro culture of macrophages with in vivo characteristics.

There is a growing general interest in studying- or using polarized canine macrophages and this is reflected in the literature. For example, canine macrophages can be used as infection models in which polarization can play an important role. Leishmania is an important pathogen of dogs and both the DH82 cell line [53] as well as canine MDMs [54] were used to study the effect of Leishmania infection. Canine MDMs were also used to study Mycobacterium intracellulare infection, which polarized the MDM towards M1 [55]. Besides microorganisms changing polarization of macrophages, also communication between immune cells leading to polarization has been studied in which canine B-cells were able to switch M1 macrophages to M2 -like macrophages [56]. Finally the effect of extracellular vesicles on canine macrophages [57] or canine M1 macrophage EVs themselves on apoptosis [58] have also been described. These examples indicate again that there is a need for a well-defined and well described macrophage model system to obtain reliable and well-interpretable results.

In conclusion, in this study we successfully developed a polarization protocol for canine monocytes, and the resulting M1 and M2 macrophage types were comprehensively characterized. The two subsets differ significantly in morphology, gene and protein expression, and functionality and are an excellent model for future research on (polarized) canine macrophage studies.

Supporting information

S1 Table. Gene counts of M0 monocytes and M1, M2 macrophages and CD14+ and CD14D cells.

(XLSX)

S2 Table. Differentially expressed genes of M0 monocytes, M1, M2 macrophages and CD14+ and CD14D cells.

(XLSX)

S3 Table. Top 50 DEG pairwise comparisons M0, M1, M2 and CD14+ cells.

(XLSX)

S1 Fig. Identification of non-viable cells by back gating.

(PDF)

S2 Fig. Selection of Immunity-related DEG’s.

(TIF)

S1 Video

A. Bead uptake M0 monocytes visualized by confocal microscopy. B. Bead uptake M1 MDMs visualized by confocal microscopy. C. Bead uptake M2 MDMs visualized by confocal microscopy.

(ZIP)

Acknowledgments

The authors thank Evieke Ruijsink for collecting flow cytometry data from one of the donor dogs. All fluorescent microscopy images have been acquired at the Center of Cellular Imaging, Faculty of Veterinary Medicine, Utrecht University. All the flow cytometry data were collected using the Flow Cytometry and Cell Sorting Facility at the department of Infectious Diseases & Immunology in Utrecht University.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The China Scholarship Council (CSC) offered a scholarship with award number 201606170114 to Qingkang Lyu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Rowell JL, McCarthy DO, Alvarez CE. Dog models of naturally occurring cancer. Trends Mol Med. 2011;17(7):380–8. doi: 10.1016/j.molmed.2011.02.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Day MJ. Antigen specificity in canine autoimmune haemolytic anaemia. Vet Immunol Immunopathol. 1999;69(2–4):215–24. doi: 10.1016/s0165-2427(99)00055-0 [DOI] [PubMed] [Google Scholar]
  • 3.Sinke JD, Rutten VP, Willemse T. Immune dysregulation in atopic dermatitis. Vet Immunol Immunopathol. 2002;87(3–4):351–6. doi: 10.1016/s0165-2427(02)00066-1 [DOI] [PubMed] [Google Scholar]
  • 4.Wang C, Yu X, Cao Q, Wang Y, Zheng G, Tan TK, et al. Characterization of murine macrophages from bone marrow, spleen and peritoneum. BMC Immunol. 2013;14:6. doi: 10.1186/1471-2172-14-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Hirayama D, Iida T, Nakase H. The Phagocytic Function of Macrophage-Enforcing Innate Immunity and Tissue Homeostasis. International Journal of Molecular Sciences. 2018;19(1):92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ito T, Connett JM, Kunkel SL, Matsukawa A. The linkage of innate and adaptive immune response during granulomatous development. Front Immunol. 2013;4:10. doi: 10.3389/fimmu.2013.00010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nature reviews Immunology. 2011;11(11):723–37. doi: 10.1038/nri3073 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000;164(12):6166–73. doi: 10.4049/jimmunol.164.12.6166 [DOI] [PubMed] [Google Scholar]
  • 9.Munder M, Eichmann K, Moran JM, Centeno F, Soler G, Modolell M. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol. 1999;163(7):3771–7. [PubMed] [Google Scholar]
  • 10.Atri C, Guerfali FZ, Laouini D. Role of Human Macrophage Polarization in Inflammation during Infectious Diseases. Int J Mol Sci. 2018;19(6). doi: 10.3390/ijms19061801 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Abdelaziz MH, Abdelwahab SF, Wan J, Cai W, Huixuan W, Jianjun C, et al. Alternatively activated macrophages; a double-edged sword in allergic asthma. J Transl Med. 2020;18(1):58. doi: 10.1186/s12967-020-02251-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Yao Y, Xu XH, Jin L. Macrophage Polarization in Physiological and Pathological Pregnancy. Front Immunol. 2019;10:792. doi: 10.3389/fimmu.2019.00792 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425–40. doi: 10.1002/jcp.26429 [DOI] [PubMed] [Google Scholar]
  • 14.Wang N, Liang H, Zen K. Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front Immunol. 2014;5:614. doi: 10.3389/fimmu.2014.00614 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Arora S, Dev K, Agarwal B, Das P, Syed MA. Macrophages: Their role, activation and polarization in pulmonary diseases. Immunobiology. 2018;223(4–5):383–96. doi: 10.1016/j.imbio.2017.11.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Murray PJ. Macrophage Polarization. Annu Rev Physiol. 2017;79:541–66. doi: 10.1146/annurev-physiol-022516-034339 [DOI] [PubMed] [Google Scholar]
  • 17.Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014;6:13. doi: 10.12703/P6-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Heinrich F, Lehmbecker A, Raddatz BB, Kegler K, Tipold A, Stein VM, et al. Morphologic, phenotypic, and transcriptomic characterization of classically and alternatively activated canine blood-derived macrophages in vitro. PLoS One. 2017;12(8):e0183572. doi: 10.1371/journal.pone.0183572 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Chow L, Soontararak S, Wheat W, Ammons D, Dow S. Canine polarized macrophages express distinct functional and transcriptomic profiles. Front Vet Sci. 2022;9:988981. doi: 10.3389/fvets.2022.988981 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Herrmann I, Gotovina J, Fazekas-Singer J, Fischer MB, Hufnagl K, Bianchini R, et al. Canine macrophages can like human macrophages be in vitro activated toward the M2a subtype relevant in allergy. Dev Comp Immunol. 2018;82:118–27. [DOI] [PubMed] [Google Scholar]
  • 21.Lindblad-Toh K, Wade CM, Mikkelsen TS, Karlsson EK, Jaffe DB, Kamal M, et al. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature. 2005;438(7069):803–19. doi: 10.1038/nature04338 [DOI] [PubMed] [Google Scholar]
  • 22.Kim KS, Lee SE, Jeong HW, Ha JH. The complete nucleotide sequence of the domestic dog (Canis familiaris) mitochondrial genome. Mol Phylogenet Evol. 1998;10(2):210–20. doi: 10.1006/mpev.1998.0513 [DOI] [PubMed] [Google Scholar]
  • 23.van den Biggelaar R, van Eden W, Rutten V, Jansen CA. Macrophage Activation Assays to Evaluate the Immunostimulatory Capacity of Avibacterium paragallinarum in A Multivalent Poultry Vaccine. Vaccines (Basel). 2020;8(4). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Mendoza-Coronel E, Ortega E. Macrophage Polarization Modulates FcγR- and CD13-Mediated Phagocytosis and Reactive Oxygen Species Production, Independently of Receptor Membrane Expression. Front Immunol. 2017;8:303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Helft J, Bottcher J, Chakravarty P, Zelenay S, Huotari J, Schraml BU, et al. GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c(+)MHCII(+) Macrophages and Dendritic Cells. Immunity. 2015;42(6):1197–211. doi: 10.1016/j.immuni.2015.05.018 [DOI] [PubMed] [Google Scholar]
  • 26.Hytonen MK, Lohi H. Canine models of human rare disorders. Rare Dis. 2016;4(1):e1241362. doi: 10.1080/21675511.2016.1241362 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Gao J, Scheenstra MR, van Dijk A, Veldhuizen EJ, Haagsman HP. A new and efficient culture method for porcine bone marrow-derived M1-and M2-polarized macrophages. Veterinary immunology and immunopathology. 2018;200:7–15. doi: 10.1016/j.vetimm.2018.04.002 [DOI] [PubMed] [Google Scholar]
  • 28.Banete A, Achita P., Harding K., Mulder R., Basta S. Immortalized murine macrophage cell line as a model for macrophage polarization into classically activated M (IFNgamma+ LPS) or alternatively activated M (IL-4) macrophages. Journal of clinical & cellular immunology. 2015;6:4172–8. [Google Scholar]
  • 29.Shiratori H, Feinweber C, Luckhardt S, Linke B, Resch E, Geisslinger G, et al. THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitro. Mol Immunol. 2017;88:58–68. doi: 10.1016/j.molimm.2017.05.027 [DOI] [PubMed] [Google Scholar]
  • 30.Kosmac K, Peck BD, Walton RG, Mula J, Kern PA, Bamman MM, et al. Immunohistochemical Identification of Human Skeletal Muscle Macrophages. Bio Protoc. 2018;8(12). doi: 10.21769/BioProtoc.2883 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Raggi F, Pelassa S, Pierobon D, Penco F, Gattorno M, Novelli F, et al. Regulation of Human Macrophage M1-M2 Polarization Balance by Hypoxia and the Triggering Receptor Expressed on Myeloid Cells-1. Front Immunol. 2017;8:1097. doi: 10.3389/fimmu.2017.01097 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Leuti A, Talamonti E, Gentile A, Tiberi M, Matteocci A, Fresegna D, et al. Macrophage Plasticity and Polarization Are Altered in the Experimental Model of Multiple Sclerosis. Biomolecules. 2021;11(6). doi: 10.3390/biom11060837 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Qu X, Cinar MU, Fan H, Proll M, Tesfaye D, Tholen E, et al. Comparison of the innate immune responses of porcine monocyte-derived dendritic cells and splenic dendritic cells stimulated with LPS. Innate Immun. 2015;21(3):242–54. doi: 10.1177/1753425914526266 [DOI] [PubMed] [Google Scholar]
  • 34.Milhau N, Almouazen E, Bouteille S, Hellel-Bourtal I, Azzouz-Maache S, Benavides U, et al. In vitro evaluations on canine monocyte-derived dendritic cells of a nanoparticles delivery system for vaccine antigen against Echinococcus granulosus. PLoS One. 2020;15(2):e0229121. doi: 10.1371/journal.pone.0229121 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Sylvestre M, Crane CA, Pun SH. Progress on Modulating Tumor-Associated Macrophages with Biomaterials. Adv Mater. 2020;32(13):e1902007. doi: 10.1002/adma.201902007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Rey-Giraud F, Hafner M, Ries CH. In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions. PLoS One. 2012;7(8):e42656. doi: 10.1371/journal.pone.0042656 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Saha B, Bruneau JC, Kodys K, Szabo G. Alcohol-induced miR-27a regulates differentiation and M2 macrophage polarization of normal human monocytes. J Immunol. 2015;194(7):3079–87. doi: 10.4049/jimmunol.1402190 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Saqib U, Sarkar S, Suk K, Mohammad O, Baig MS, Savai R. Phytochemicals as modulators of M1-M2 macrophages in inflammation. Oncotarget. 2018;9(25):17937–50. doi: 10.18632/oncotarget.24788 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Peng H, Geil Nickell CR, Chen KY, McClain JA, Nixon K. Increased expression of M1 and M2 phenotypic markers in isolated microglia after four-day binge alcohol exposure in male rats. Alcohol. 2017;62:29–40. doi: 10.1016/j.alcohol.2017.02.175 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Sironi M, Martinez FO, D’Ambrosio D, Gattorno M, Polentarutti N, Locati M, et al. Differential regulation of chemokine production by Fcgamma receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2). J Leukoc Biol. 2006;80(2):342–9. doi: 10.1189/jlb.1005586 [DOI] [PubMed] [Google Scholar]
  • 41.Pahl JH, Kwappenberg KM, Varypataki EM, Santos SJ, Kuijjer ML, Mohamed S, et al. Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-gamma. J Exp Clin Cancer Res. 2014;33:27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Wallner S, Grandl M, Konovalova T, Sigruner A, Kopf T, Peer M, et al. Monocyte to macrophage differentiation goes along with modulation of the plasmalogen pattern through transcriptional regulation. PLoS One. 2014;9(4):e94102. doi: 10.1371/journal.pone.0094102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Durafourt BA, Moore CS, Zammit DA, Johnson TA, Zaguia F, Guiot MC, et al. Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia. 2012;60(5):717–27. doi: 10.1002/glia.22298 [DOI] [PubMed] [Google Scholar]
  • 44.Leidi M, Gotti E, Bologna L, Miranda E, Rimoldi M, Sica A, et al. M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro. J Immunol. 2009;182(7):4415–22. doi: 10.4049/jimmunol.0713732 [DOI] [PubMed] [Google Scholar]
  • 45.Tarique AA, Logan J, Thomas E, Holt PG, Sly PD, Fantino E. Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages. Am J Respir Cell Mol Biol. 2015;53(5):676–88. doi: 10.1165/rcmb.2015-0012OC [DOI] [PubMed] [Google Scholar]
  • 46.Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122(3):787–95. doi: 10.1172/JCI59643 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Krzyszczyk P, Schloss R, Palmer A, Berthiaume F. The Role of Macrophages in Acute and Chronic Wound Healing and Interventions to Promote Pro-wound Healing Phenotypes. Front Physiol. 2018;9:419. doi: 10.3389/fphys.2018.00419 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nature reviews Immunology. 2008;8(7):533–44. doi: 10.1038/nri2356 [DOI] [PubMed] [Google Scholar]
  • 49.Hamidzadeh K, Belew AT, El-Sayed NM, Mosser DM. The transition of M-CSF-derived human macrophages to a growth-promoting phenotype. Blood Adv. 2020;4(21):5460–72. doi: 10.1182/bloodadvances.2020002683 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Jeannin P, Paolini L, Adam C, Delneste Y. The roles of CSFs on the functional polarization of tumor-associated macrophages. FEBS J. 2018;285(4):680–99. doi: 10.1111/febs.14343 [DOI] [PubMed] [Google Scholar]
  • 51.Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol. 2006;177(10):7303–11. doi: 10.4049/jimmunol.177.10.7303 [DOI] [PubMed] [Google Scholar]
  • 52.Stout RD, Jiang C, Matta B, Tietzel I, Watkins SK, Suttles J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol. 2005;175(1):342–9. doi: 10.4049/jimmunol.175.1.342 [DOI] [PubMed] [Google Scholar]
  • 53.Nadaes NR, Silva da Costa L, Santana RC, LaRocque-de-Freitas IF, Vivarini AC, Soares DC, et al. DH82 Canine and RAW264.7 Murine Macrophage Cell Lines Display Distinct Activation Profiles Upon Interaction With Leishmania infantum and Leishmania amazonensis. Front Cell Infect Microbiol. 2020;10:247. doi: 10.3389/fcimb.2020.00247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Diaz S, da Fonseca IP, Rodrigues A, Martins C, Cartaxeiro C, Silva MJ, et al. Canine leishmaniosis. Modulation of macrophage/lymphocyte interactions by L. infantum. Vet Parasitol. 2012;189(2–4):137–44. doi: 10.1016/j.vetpar.2012.05.004 [DOI] [PubMed] [Google Scholar]
  • 55.Kim S, Hyun YS, Park HT, Shin MK, Yoo HS. Mycobacterium intracellulare induces a Th17 immune response via M1-like macrophage polarization in canine peripheral blood mononuclear cells. Sci Rep. 2022;12(1):11818. doi: 10.1038/s41598-022-16117-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Jang HW, An JH, Kim KB, Lee JH, Oh YI, Park SM, et al. Canine peripheral blood mononuclear cell-derived B lymphocytes pretreated with lipopolysaccharide enhance the immunomodulatory effect through macrophage polarization. PLoS One. 2021;16(11):e0256651. doi: 10.1371/journal.pone.0256651 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Park SM, An JH, Lee JH, Kim KB, Chae HK, Oh YI, et al. Extracellular vesicles derived from DFO-preconditioned canine AT-MSCs reprogram macrophages into M2 phase. PLoS One. 2021;16(7):e0254657. doi: 10.1371/journal.pone.0254657 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Lee KM, An JH, Yang SJ, Park SM, Lee JH, Chae HK, et al. Influence of Canine Macrophage-derived Extracellular Vesicles on Apoptosis in Canine Melanoma and Osteosarcoma Cell Lines. Anticancer Res. 2021;41(2):719–30. doi: 10.21873/anticanres.14823 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Kenji Fujiwara

28 Feb 2023

PONE-D-23-02588Characterization of polarization states of canine monocyte derived macrophages.PLOS ONE

Dear Dr. Veldhuizen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 14 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Kenji Fujiwara, PhD, MD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating the following financial disclosure: 

"The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. 

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

5. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 

Additional Editor Comments:

Dear Dr. Veldhuizen.

The article is about the characteristics of canine macrophages. The results seem almost similar to human macrophages, and the similarity could attract many readers. The manuscript is well-written and I think this is eligible to be considered for major revision by agreeing with the reviewers. I added some minor concerns below.

I look forward to the revised one.

Best regards,

Kenji Fujiwara

Minor concerns

1. American English may be appropriate. For example, “RNAseq of the three macrophage subsets showed distinct gene expression profiles, which are closely associated with immune responsiveness, cell differentiation and phagocytosis.”

2. In the abstract, “M2- polarized MDMs” suddenly appeared. Please show elaboration of MDM at first appearance.

3. I think PLOS ONE does not ask to add keywords on the title page. Also, figure legends and a table should be in the result section. Please check the guideline.

https://journals.plos.org/plosone/s/submission-guidelines

4. In Figure 3A, the numbers in the Venn diagrams seem too small. Could you change them to larger for readers? This issue is the same for Figures 4 and 5.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 

The manuscript "Characterization of polarization states of canine monocyte-derived macrophages" is well-written and experimentally well-conducted.

Canine macrophage polarization still has a poor level of scientific understanding. In this study, the authors polarized canine monocytes toward M1 and M2 macrophages and contrasted them to unpolarized M0 cells. The authors characterized polarized M1 and M2 and unpolarized M0 macrophages by morphology, gene profiles, surface marker features, and functional properties. The following analysis revealed that canine macrophages M1, M2, and M0 differ from one another and can be identified based on their phenotypic characteristics and the expression of particular markers, just like macrophages from other well-studied species. RNAseq revealed the three macrophage subsets' gene expression patterns closely related to phagocytosis, cell differentiation, and immune responsiveness. No new polarization markers could, however, be assigned by the authors.

Future research on (polarized) canine macrophage studies will benefit significantly from monocyte-derived polarized macrophages, particularly in studies of immune-related diseases in dogs. The differentiation protocols produced two subsets of macrophages (M1 and M2) that differ significantly in morphology, gene and protein expression, and functionality. These subsets are also a great model for future research on macrophage studies in general.

Recommendations.

The manuscript is accepted with minor revisions.

1) Discussion: add more biological information about DEGs found in M1 and M2 macrophages.

2) Add more information regarding the significance of the DEGs specific for each subset of macrophages.

Reviewer #2: Dear,

The authors explored an interesting research field and the main goal of the manuscript is really necessary to understand the macrophage polarization for canine monocytes. The authors proposed a protocol to characterize the macrophage polarization, and the main approaches were considered but it should be improved. The major concern is the basic experimental design to induce the macrophage polarization because the authors called M0 macrophages a cell type that was not differentiated to macrophage and is a monocyte. Moreover, the authors should demonstrated that most of the results found were not already induced by M/GM-CSF, then control groups containing only M-CSF or GM-CSF is strongly recommended. LPS can also induce some characteristics related to the M2 macrophages for murine and human cells in a dose-dependent manner, then it should be discussed by the authors or demonstrate that 100ng/mL of LPS is adequate to evaluate only M1 macrophage. The association of IL-12 and IFN-g could be a better option for M1 macrophage induction. So, the impact of LPS/IFN and IL-4 in the macrophage polarization is confused with M/GM-CSF and so far there is no M0 macrophage.

In addition, iNOs and Arginase-1 were missed and must be evaluated to complement the flow cytometry data, and both mRNA relative expression and protein expression are well accepted. The morphological analysis should be improved, and H&E staining is an example for that. The phagocytosis assay could consider the incubation with IFN-g alone for each condition as a positive control to facilitate the engulfment of beads.

The plasticity of canine monocytes should be validated by the repolarization assay, and the balance between iNOS/Arginase-1 is a great parameter to demonstrate that M1/M2 subsets can be repolarized.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: MARCO ANTONIO MERAZ RIOS

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Nov 8;18(11):e0292757. doi: 10.1371/journal.pone.0292757.r002

Author response to Decision Letter 0


6 Jul 2023

editorial remarks

Minor concerns

1. American English may be appropriate. For example, “RNAseq of the three macrophage subsets showed distinct gene expression profiles, which are closely associated with immune responsiveness, cell differentiation and phagocytosis.”

Reply: We corrected the text to American English where appropriate.

2. In the abstract, “M2- polarized MDMs” suddenly appeared. Please show elaboration of MDM at first appearance.

Reply: We removed MDMs from the abstract. In the manuscript itself it is now described as monocyte-derived macrophages upon its first appearance Line 116.

3. I think PLOS ONE does not ask to add keywords on the title page. Also, figure legends and a table should be in the result section. Please check the guideline.

https://journals.plos.org/plosone/s/submission-guidelines

Reply: Keywords have been removed and the figure legends and table have been moved to the correct position in the manuscript text.

4. In Figure 3A, the numbers in the Venn diagrams seem too small. Could you change them to larger for readers? This issue is the same for Figures 4 and 5.

Reply: We have changed the fonts in Fig 3- 5 to make them easier to read.

Reviewer #1:

The manuscript "Characterization of polarization states of canine monocyte-derived macrophages" is well-written and experimentally well-conducted.

Canine macrophage polarization still has a poor level of scientific understanding. In this study, the authors polarized canine monocytes toward M1 and M2 macrophages and contrasted them to unpolarized M0 cells. The authors characterized polarized M1 and M2 and unpolarized M0 macrophages by morphology, gene profiles, surface marker features, and functional properties. The following analysis revealed that canine macrophages M1, M2, and M0 differ from one another and can be identified based on their phenotypic characteristics and the expression of particular markers, just like macrophages from other well-studied species. RNAseq revealed the three macrophage subsets' gene expression patterns closely related to phagocytosis, cell differentiation, and immune responsiveness. No new polarization markers could, however, be assigned by the authors.

Future research on (polarized) canine macrophage studies will benefit significantly from monocyte-derived polarized macrophages, particularly in studies of immune-related diseases in dogs. The differentiation protocols produced two subsets of macrophages (M1 and M2) that differ significantly in morphology, gene and protein expression, and functionality. These subsets are also a great model for future research on macrophage studies in general.

Recommendations.

The manuscript is accepted with minor revisions.

1) Discussion: add more biological information about DEGs found in M1 and M2 macrophages.

Reply: We have added several lines on the biological information in the discussion. Line 481-484.

2) Add more information regarding the significance of the DEGs specific for each subset of macrophages.

Reply: From the RNAseq data we selected gene expression levels of some described M1 or M2 markers. This shows that indeed, for example Il-6 and IL-1β are much higher in M1 compared to M2 while TGF- β is higher in M2. Surprisingly arginase expression does not show major differences. We added this as a supplementary figure to the manuscript and describe the results in lines 358-363.

Reviewer #2: Dear,

1) The authors explored an interesting research field and the main goal of the manuscript is really necessary to understand the macrophage polarization for canine monocytes. The authors proposed a protocol to characterize the macrophage polarization, and the main approaches were considered but it should be improved. The major concern is the basic experimental design to induce the macrophage polarization because the authors called M0 macrophages a cell type that was not differentiated to macrophage and is a monocyte.

Reply: We thanks the reviewer for the nice remarks and indeed agree that M0 are not macrophages. We have now changed the terminology throughout the whole manuscript to either M0 monocytes or M0 cells.

However, regarding the 1st remark about the basic design, (and this will come back in the rebuttal below), we feel that our aim of the manuscript was not clearly brought across. We do not seek to optimize the protocol to make polarized canine macrophages, but instead we want to characterize the polarized macrophages that are obtained using a standardized method. This method is well described in human and mouse, and recently a very small number of canine studies also used this protocol based on GM-CSF/IFNγ/LPS and M-CSF/IL-4. Finding the best protocol is a completely different study requiring a completely different set-up. In addition, we would not know how to clearly define ‘an improved method’ because it would be based on human and mouse macrophage readouts and would deny possible species differences in macrophage polarization and functionality. We added a few sentences in the discussion to emphasize this aim of our study again. Line 506-511.

2) Moreover, the authors should demonstrated that most of the results found were not already induced by M/GM-CSF, then control groups containing only M-CSF or GM-CSF is strongly recommended.

Reply: We performed these experiments as requested and polarized M0 cells towards M1/M2 using either GM-CSF / M-CSF alone, or with the addition IFN-γ/LPS and IL-4. We performed qPCR on specific M1 and M2 markers and also checked the cell’s morphology. These experiments showed that indeed the presence of the growth factors alone already had strong polarizing activity, as seen by the morphology, see Figure E(xtra)1 below . However, the ‘extra’ addition of IFN-γ / LPS resulted in an upregulation of IL-6 (M1 marker) compared to GM-CSF alone, while addition of IL-4 induced gene expression of TGF-beta and MS4A2 (M2 marker), showing that these factors have an additional effect on gene expression of polarization marker genes (Fig. E2). These actual experiments are, however outside the scope of the manuscript. We have included a comment on our findings in the discussion. Line 532-536.

(see figure in 'response to reviewer file at end of document'; figures couldn't be copied in this section)

Fig E1. Morphology of M1 and M2 macrophages on day 8 after polarization. Polarization with GM-CSF with or without IFNγ/LPS resulted in a M1 phenotype. Polarization with M-CSF with or without IL-4 resulted in a M2 phenotype.

(see figure in 'response to reviewer file at end of document'; figures couldn't be copied in this section)

Fig. E2. Relative gene expression of cells matured in the presence of A) GM-CSF ± IFN/LPS and B) M-CSF ± IL-4.

3) LPS can also induce some characteristics related to the M2 macrophages for murine and human cells in a dose-dependent manner, then it should be discussed by the authors or demonstrate that 100ng/mL of LPS is adequate to evaluate only M1 macrophage.

Reply: We agree with the reviewer that LPS indeed can cause some M2 characteristics. Before performing our study on monocyte derived macrophages we did some initial studies on the effect on LPS on canine macrophages in the macrophage cell line 030D which indicated that this concentration indeed induced classical M1 markers. Eventually, the results of our monocyte derived macrophages polarization also shows that this methodology indeed results in M1 like features.

4) The association of IL-12 and IFN-g could be a better option for M1 macrophage induction. So, the impact of LPS/IFN and IL-4 in the macrophage polarization is confused with M/GM-CSF and so far there is no M0 macrophage.

Reply: We agree with the reviewer that several variables in the polarization methodology have not been explored, including the use of IL-12 and IFNy. However, as stated above, the focus of this study is not to optimize the polarization method.

We agree with the wrong use of the term M0 macrophages and this has been replaced throughout the manuscript.

5) In addition, iNOs and Arginase-1 were missed and must be evaluated to complement the flow cytometry data, and both mRNA relative expression and protein expression are well accepted.

Reply: We have added the gene expression of several key genes in supplementary Figure S1 , including iNOS and Arginase1 and discuss these in the manuscript, line 358-363. Unfortunately we don’t have assays running for determination of these enzymes on a protein level (much less tools are available for canine research than mouse and human).

6) The morphological analysis should be improved, and H&E staining is an example for that.

Reply: Unfortunately , we made an error in the morphological analyses of our polarized macrophages in our new set of experiments, and only stained with Hematoxylin. We added these stainings below for your convenience but realize they don’t add any value. However, we are not completely sure what the reviewer would like to see with a correct H&E staining. If it is essential, we are willing to obtain fresh canine blood, polarize monocytes to macrophages and perform the analysis. But considering the infrequency of obtaining fresh buffy coats from (canine) patients we doubt if the extra effort is really required.

7) The phagocytosis assay could consider the incubation with IFN-g alone for each condition as a positive control to facilitate the engulfment of beads.

Reply: We agree that many variables can be tested to optimize phagocytosis or other characteristics of polarized macrophages. But this falls out of the scope of the current manuscript which is a characterization of in vitro M1 and M2 polarized macrophages in dogs. The contribution of each polarization-inducing compound is subject to a follow up study.

8) The plasticity of canine monocytes should be validated by the repolarization assay, and the balance between iNOS/Arginase-1 is a great parameter to demonstrate that M1/M2 subsets can be repolarized.

Reply: In our extra set of experiments of experiments we used our day8 M1 and M2 polarized macrophages and treated them with the opposite polarizing environments. So M2 polarized macrophages were grown for an additional 2 days in the presence of GM-CSF/ IFN-γ and LPS and day 8 M1 polarized macrophages were grown an additional 2 days in the presence of M-CSF and Il-4. Control M1 and M2 macrophages were grown an additional 2 days in their original growth medium. Clear morphological changes were observed for M2� M1 repolarization (Fig. E3), and also gene expression of IL-6, was upregulated (Fig. E4). The M1�M2 repolarization was more subtle in both aspects. Morphological changes were less clear, and we didn’t see the typical M2-like morphology. However, on a gene level a tendency towards more MS4A2 (M2 marker) gene expression was observed. Based on these results we can conclude that at day 8 both M1 and M2 had not reached an end-point polarization state and still had plasticity. However, we cannot state that they repolarized to classical M1 or M2 macrophages. We made a comment about the importance of repolarization in the discussion in Line 532-536. We will pursue the re-polarization study in our planned follow up studies, also optimizing this repolarization protocol.

(see figure in 'response to reviewer file at end of document'; figures couldn't be copied in this section)

Fig. E3. Morphology of repolarized macrophages on day 10 after (re-)polarization. Day 8 M1 macrophages did not clearly change morphology after 2 days repolarization with M2 conditions (top left vs top right image). M2 macrophages on the other hand clearly depicted a mor eM1-like morphology after repolarization in M1 conditions (compare bottom left and bottom right image. Fig. E4. Relative gene expression of cells matured for 8 days towards M1 or M2, and on day 9 repolarized towards opposite polarization state. ________________________________________

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Attachment

Submitted filename: Lyu et al response to reviewers.docx

Decision Letter 1

Kenji Fujiwara

31 Jul 2023

PONE-D-23-02588R1Characterization of polarization states of canine monocyte derived macrophages.PLOS ONE

Dear Dr. Veldhuizen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

I think the manuscript was revised well. One reviewer asked some questions and I agree with the concerns. After receiving minor revisions, we will reevaluate again.

Please submit your revised manuscript by Sep 14 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Kenji Fujiwara, PhD, MD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Dear Dr. Veldhuizen.

I think the manuscript was revised well. One reviewer asked some questions and I agree with the concerns. After receiving minor revisions, we will reevaluate again.

Best,

Kenji Fujiwara

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The reviewers' criticisms have been appropriately resolved by the authors, and the work is now suitable for publishing.

Reviewer #3: The manuscript "Characterization of polarization states of canine monocyte-derived macrophages" provides phenotypic descriptions of polarization of canine macrophages in pro-inflammatory M1 and pro-resolution M2 states. Authors used well characterized methods to induce their polarization, allowing for more direct comparison between their canine model and other mammal models such as human and mouse. Authors also measured well characterized endpoints including phagocytosis, cell surface receptor levels, and RNAseq plus GO/KEGG analysis which provides strong evidence for similarities between canine macrophage polarization states and human/mouse macrophages. The findings described within are interesting and overall, well presented, however the use of M0 to describe undifferentiated monocytes remains an issue. While authors have modified their description in the methods and in most instances in the rest of the text, some instances remain unchanged from the original description. Regardless, I believe the use of M0 to describe undifferentiated monocytes introduces unnecessary confusion due to its usual use to describe unpolarized macrophages following differentiation from monocytes and should be removed entirely, replaced with “undifferentiated monocytes (UM)” or similar. I would also recommend additional citations, particularly in the discussion, when referencing the use of these methods in other species as well as known or suspected responses in other species.

Major comments:

1. Based on the methods description and to avoid confusion with terminology used in the literature, the use of M0 for undifferentiated monocytes should be removed and replaced with “undifferentiated monocytes (UM)” or similar. If authors insist on maintaining this terminology, careful attention should be paid to their use of M0, as its use in numerous places incorrectly stated or (to me) implied they were in fact monocyte-derived macrophages. See line 31, 279, 305, 417-419, 479. Further, in the abstract and throughout “un differentiated” should be changed to “undifferentiated”. Each figure legend should also clearly indicate that M0=undifferentiated monocyte.

2. I disagree with the author’s reply to reviewer 2, comment 2 in regard to excluding the results of their additional experiment from the manuscript. GM-CSF/M-CSF alone inducing M1/M2-like polarization absent additional stimuli has been previously described in other models and appears true for authors’ model as well. Their description of IL-6/TGF-b/MS4A2 upregulation following additional stimuli suggests the addition of IFNy+LPS/IL4 is adding to the polarization as in other models. If the authors do not feel these specific results are appropriate to include, I would recommend they at least add a comment to the discussion (with appropriate citations) to describe this known phenomenon. I believe this was attempted in lines 506-511, but citations should be included and comments describing findings in human/mouse cells should be used to compare to these findings, despite possible differences between responses due to species.

3. While videos were referenced throughout the manuscript, especially in Figure 6 legend, they are not listed under “Supplementary Files” and were not linked to the review. I was unable to access supplemental materials Video S1A, B, and C and therefore cannot comment on them.

4. For transparency, please add individual dots for each subject onto new Figure S1 (currently bar plot, but would be ideally shown with mean, error, and individual data points). This should also be applied to bar plots in figures 1C, 2B and 6B. Currently unclear whether N=3 was averaged across triplicate or whether all 9 datapoints were used to create graphs, the former is the most appropriate.

Minor Comments:

5. Please provide more information on the donor dogs in section 2.1. A clear listing of how many samples were collected, age, the sex of the animal, and optionally the breed should be listed.

6. Line 190 states “Transcripts with read counts <2 were filtered out for DEG testing.” Please clarify if this is filtering based on single sample (any sample <2 excludes gene for all samples), all samples (all samples had to be >=2 or excludes gene), or mean counts (assessed by group or of all samples).

7. In Figure 1B, the M1 macrophage panel shows a sizable population of events at approximately 35 degrees which is not present in M0 or M2 panels. This appears independent of what I assume is debris which is present in all panels including M1 at approximately 20 degrees. Do the authors have any information about this population, i.e. did they attempt to measure live/dead of this population to determine if these are dead/dying cells? This relates to Figure 6A which uses a representative panel to describe gating which does not possess this population.

8. Replace “Representable” with “Representative” on line 307.

9. Figure 3B may benefit from vertical breaks between samples to allow for easier comparison between replicates. In the legend for 3B please change to “differentially expressed genes” and indicate whether p-value was also used as a cutoff for inclusion in the heatmap.

10. Please add that PCA was created using FPKM in Figure 4’s legend.

11. Unsure what authors mean on line 399-402. Consider rephrasing.

12. The last sentence of the conclusion should read “…in morphology, gene and protein expression, and functionality…”

13. In Figure 6A, is there a horizontal gap between cell populations allowing for a 1 bead/cell and multiple beads/cell events that was used to draw gates? I am unable to assess this due to the panel size/resolution.

14. Lines 481-483. I generally agree, please add citations of these previous findings.

15. Line 494. “Deducted” should be “deduced”.

16. Line 532-536. I agree with this statement, but citations should be provided to describe previous findings suggesting this possibility.

17. Line 543-544. This sentence is confusing as is. Please consider rephrasing.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: MARCO ANTONIO MERAZ RIOS

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Nov 8;18(11):e0292757. doi: 10.1371/journal.pone.0292757.r004

Author response to Decision Letter 1


29 Aug 2023

Major comments:

1. Based on the methods description and to avoid confusion with terminology used in the literature, the use of M0 for undifferentiated monocytes should be removed and replaced with “undifferentiated monocytes (UM)” or similar. If authors insist on maintaining this terminology, careful attention should be paid to their use of M0, as its use in numerous places incorrectly stated or (to me) implied they were in fact monocyte-derived macrophages. See line 31, 279, 305, 417-419, 479. Further, in the abstract and throughout “un differentiated” should be changed to “undifferentiated”. Each figure legend should also clearly indicate that M0=undifferentiated monocyte.

We decided to maintain the M0 terminology to depict the common origin as the M1 and M2 macrophages, but we replaced ‘M0 cells’ with ‘undifferentiated monocytes’ at multiple (>20) places in the manuscript, including all the figure legends. This should clarify even more that M0 cells are indeed monocytes and not macrophages. The spaces between ‘un’ and ‘differentiated’have been removed.

2. I disagree with the author’s reply to reviewer 2, comment 2 in regard to excluding the results of their additional experiment from the manuscript. GM-CSF/M-CSF alone inducing M1/M2-like polarization absent additional stimuli has been previously described in other models and appears true for authors’ model as well. Their description of IL-6/TGF-b/MS4A2 upregulation following additional stimuli suggests the addition of IFNy+LPS/IL4 is adding to the polarization as in other models. If the authors do not feel these specific results are appropriate to include, I would recommend they at least add a comment to the discussion (with appropriate citations) to describe this known phenomenon. I believe this was attempted in lines 506-511, but citations should be included and comments describing findings in human/mouse cells should be used to compare to these findings, despite possible differences between responses due to species.

We don’t feel completely comfortable adding our data in the current form, both because we would include many more samples for firm conclusions (and statistical significance of ALL affected genes), and because of the fact that it actually distracts from the focus of the manuscript which is to compare human vs canine polarized macrophages (instead of deciphering and optimizing canine macrophage polarization itself. However, we added a paragraph in the discussion in which we describe this phenomenon known in human macrophage polarization, thus large effects of M-CSF and GM-CSF alone, but additional polarizing effects upon addition of LPS or IL-4, including the appropriate references. Lines 517-529 of track-changes version of the manuscript.

3. While videos were referenced throughout the manuscript, especially in Figure 6 legend, they are not listed under “Supplementary Files” and were not linked to the review. I was unable to access supplemental materials Video S1A, B, and C and therefore cannot comment on them.

Apparently something went wrong during uploading of the videos . They are now included.

4. For transparency, please add individual dots for each subject onto new Figure S1 (currently bar plot, but would be ideally shown with mean, error, and individual data points). This should also be applied to bar plots in figures 1C, 2B and 6B. Currently unclear whether N=3 was averaged across triplicate or whether all 9 datapoints were used to create graphs, the former is the most appropriate.

We agree with the reviewer and have added the individual data points to figures 1, 2 and 6 as suggested. Regarding supplementary figure S1:, we picked M1 and M2 signature genes from bulk RNA-seq from 3 donors. We then used R package DESeq2 for differential analysis. In this package, experimental repetition was considered already but the outcome is only one value of log2 fold change. Hence this figure has no error bar.

Minor Comments:

5. Please provide more information on the donor dogs in section 2.1. A clear listing of how many samples were collected, age, the sex of the animal, and optionally the breed should be listed.

We added this information to the materials section. Line 100-102 (of track-changes)

6. Line 190 states “Transcripts with read counts <2 were filtered out for DEG testing.” Please clarify if this is filtering based on single sample (any sample <2 excludes gene for all samples), all samples (all samples had to be >=2 or excludes gene), or mean counts (assessed by group or of all samples).

If one gene has read counts lower than 2 fold difference in all samples, this gene was filtered out. We clarified this now in the Materials section LINE 192 (of track changes)

7. In Figure 1B, the M1 macrophage panel shows a sizable population of events at approximately 35 degrees which is not present in M0 or M2 panels. This appears independent of what I assume is debris which is present in all panels including M1 at approximately 20 degrees. Do the authors have any information about this population, i.e. did they attempt to measure live/dead of this population to determine if these are dead/dying cells? This relates to Figure 6A which uses a representative panel to describe gating which does not possess this population.

We are indeed pretty sure that population represents dead cells, so we exclude them at the beginning.. Please see the back-gating data below.

8. Replace “Representable” with “Representative” on line 307.

We made the appropriate change (which we thought was quite a funny mistake)

9. Figure 3B may benefit from vertical breaks between samples to allow for easier comparison between replicates. In the legend for 3B please change to “differentially expressed genes” and indicate whether p-value was also used as a cutoff for inclusion in the heatmap.

We agree with the suggestion and added a vertical line among groups in figure 3. We made the textual change to differentially expressed genes, LINE 344 (track changes). In our analysis, the adjusted p value < 0.05 was used as a cutoff. We added an appropriate statement in the Figure 3B legend. LINE 344-345 (track changes)

10. Please add that PCA was created using FPKM in Figure 4’s legend.

We added this to the figure legend LINE 385 (TT)

11. Unsure what authors mean on line 399-402. Consider rephrasing.

We rephrased the sentence to clarify that there is no clear result in this analysis that indicates major immunological differences between M0 and M2. LINE 403-406 (TT)

12. The last sentence of the conclusion should read “…in morphology, gene and protein expression, and functionality…”

We made the suggested change LINE 572-573 (TT)

13. In Figure 6A, is there a horizontal gap between cell populations allowing for a 1 bead/cell and multiple beads/cell events that was used to draw gates? I am unable to assess this due to the panel size/resolution.

When the figures are ‘blown up’you can indeed see a gap between 1 bead and multiple beads, see figure below. We indicated this in the figure and the legend but have not commented on the 1 bead – multiple bead ratio (which was similar) since we think % positive cells and total MFI is more important.

14. Lines 481-483. I generally agree, please add citations of these previous findings.

we added 2 references to this statement. LINE 491 (TT)

15. Line 494. “Deducted” should be “deduced”.

we made the suggested change LINE 502 (TT)

16. Line 532-536. I agree with this statement, but citations should be provided to describe previous findings suggesting this possibility.

The reference describing repolarization has been added LINE 555 (TT)

17. Line 543-544. This sentence is confusing as is. Please consider rephrasing.

We have rephrased the sentence to clarify the statement. LINE 563-564(TT)

Decision Letter 2

Kenji Fujiwara

21 Sep 2023

PONE-D-23-02588R2Characterization of polarization states of canine monocyte derived macrophages.PLOS ONE

Dear Dr. Veldhuizen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 05 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Kenji Fujiwara, PhD, MD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

Dear Dr. Veldhuizen

The article was reviewed by the previous reviewer and minor revision was recommended. I agree with it. I look forward to the updated one.

Best regards,

Kenji Fujiwara

Academic editor

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #3: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: Overall, the authors have thoroughly addressed the majority of the reviewer comments. However, there are still a few items that require further clarification.

1. Prior comment by reviewer: Line 190 states “Transcripts with read counts <2 were filtered out for DEG testing.” Please clarify if this is filtering based on single sample (any sample <2 excludes gene for all samples), all samples (all samples had to be >=2 or excludes gene), or mean counts (assessed by group or of all samples).

author response: If one gene has read counts lower than 2 fold difference in all samples, this gene was filtered out. We clarified this now in the Materials section LINE 192 (of track changes)

New reviewer comment: It’s the reviewer’s understanding that based on the manuscript changes the authors meant “…read counts lower than 2 in all samples…” rather than “2 fold difference”, please affirm whether this is true. If 2 fold difference was intended, please edit the manuscript accordingly.

2. Prior Comment by reviewer: In Figure 1B, the M1 macrophage panel shows a sizable population of events at approximately 35 degrees which is not present in M0 or M2 panels. This appears independent of what I assume is debris which is present in all panels including M1 at approximately 20 degrees. Do the authors have any information about this population, i.e. did they attempt to measure live/dead of this population to determine if these are dead/dying cells? This relates to Figure 6A which uses a representative panel to describe gating which does not possess this population.

author response: We are indeed pretty sure that population represents dead cells, so we exclude them at the beginning.. Please see the back-gating data below.

new reviewer comment: The back-gating data was not included in the submission (or was not visible to the reviewer), therefore could not be verified. It is suggested that a supplemental figure with wider gating showing the live vs. dead population be added.

3. Figure resolution should be addressed upon final figure submission to ensure readability.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Nov 8;18(11):e0292757. doi: 10.1371/journal.pone.0292757.r006

Author response to Decision Letter 2


26 Sep 2023

Characterization of polarization states of canine monocyte derived macrophages.

Qingkang Lyu, Edwin J.A. Veldhuizen , Irene S. Ludwig, Victor P. M. G. Rutten, Willem van Eden, Alice J. A. M. Sijts and Femke Broere

Point to point reply.

Comments to the Author

Reviewer #3: Overall, the authors have thoroughly addressed the majority of the reviewer comments. However, there are still a few items that require further clarification.

1. New reviewer comment: It’s the reviewer’s understanding that based on the manuscript changes the authors meant “…read counts lower than 2 in all samples…” rather than “2 fold difference”, please affirm whether this is true. If 2 fold difference was intended, please edit the manuscript accordingly.

We confirm that this is true. Genes with <2 counts for all samples, were not taken along in the determination which genes were differentially expressed. No changes made to the manuscript.

2. new reviewer comment: The back-gating data was not included in the submission (or was not visible to the reviewer), therefore could not be verified. It is suggested that a supplemental figure with wider gating showing the live vs. dead population be added.

We have now added the figure showing back-gating as a supplementary file (Fig S1) and referred to it in the text in Line 275 of the revised manuscript.

3. Figure resolution should be addressed upon final figure submission to ensure readability.

We checked figure resolution of all figures and they are all >300 dpi.

Attachment

Submitted filename: point to point reply.docx

Decision Letter 3

Kenji Fujiwara

28 Sep 2023

Characterization of polarization states of canine monocyte derived macrophages.

PONE-D-23-02588R3

Dear Dr. Veldhuizen,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Kenji Fujiwara, PhD, MD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Dear Dr. Veldhuizen.

Thank you for revising your manuscript appropriately. All reviewers and I agreed to the acceptance.

Yours sincerely,

Kenji Fujiwara

Academic editor

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

**********

Acceptance letter

Kenji Fujiwara

31 Oct 2023

PONE-D-23-02588R3

Characterization of polarization states of canine monocyte derived macrophages.

Dear Dr. Veldhuizen:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Kenji Fujiwara

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Gene counts of M0 monocytes and M1, M2 macrophages and CD14+ and CD14D cells.

    (XLSX)

    S2 Table. Differentially expressed genes of M0 monocytes, M1, M2 macrophages and CD14+ and CD14D cells.

    (XLSX)

    S3 Table. Top 50 DEG pairwise comparisons M0, M1, M2 and CD14+ cells.

    (XLSX)

    S1 Fig. Identification of non-viable cells by back gating.

    (PDF)

    S2 Fig. Selection of Immunity-related DEG’s.

    (TIF)

    S1 Video

    A. Bead uptake M0 monocytes visualized by confocal microscopy. B. Bead uptake M1 MDMs visualized by confocal microscopy. C. Bead uptake M2 MDMs visualized by confocal microscopy.

    (ZIP)

    Attachment

    Submitted filename: Lyu et al response to reviewers.docx

    Attachment

    Submitted filename: point to point reply.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES